Address |
Zhongguancun Life Science Park Beijing Beijing 102206 China |
Employees | - |
Website | http://www.beigene.com |
Updated | 07/08/2019 |
BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. |